Targeting JAK/STAT signaling pathways in treatment of inflammatory bowel disease

被引:0
|
作者
Liang Wang
Yan Hu
Baohui Song
Yongjian Xiong
Jingyu Wang
Dapeng Chen
机构
[1] Dalian Medical University,Research and Teaching Department of Comparative Medicine
[2] First Affiliated Hospital of Dalian Medical University,Central Laboratory
[3] Dalian Medical University,Laboratory Animal Center
来源
Inflammation Research | 2021年 / 70卷
关键词
JAK/STAT; Cytokine; Inflammatory bowel disease; Intestinal inflammation; JAK inhibitor; Traditional Chinese medicine;
D O I
暂无
中图分类号
学科分类号
摘要
Janus kinase/signal transduction and transcriptional activator (JAK/STAT) signaling pathway is a transport hub for cytokine secretion and exerts its effects. The activation of JAK/STAT signaling pathway is essential for the regulation of inflammatory responses. Inappropriate activation or deletion of JAK/STAT signaling pathway is the initiator of the inflammatory response. JAK/STAT signaling pathway has been demonstrated to be involved in the process of innate and adaptive immune response to inflammatory bowel disease (IBD). In this review, we discuss the role of the JAK/STAT signaling pathway in the regulation of different cells in IBD, as well as new findings on the involvement of the JAK/STAT signaling pathway in the regulation of the intestinal immune response. The current status of JAK inhibitors in the treatment of IBD is summarized as well. This review highlights natural remedies that can serve as potential JAK inhibitors. These phytochemicals may be useful in the identification of precursor compounds in the process of designing and developing novel JAK inhibitors.
引用
收藏
页码:753 / 764
页数:11
相关论文
共 50 条
  • [21] Targeting JAK-STAT Signaling for Cancer Therapy
    Jove, R.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S17 - S17
  • [22] The Role and Therapeutic Targeting of JAK/STAT Signaling in Glioblastoma
    Ou, Alexander
    Ott, Martina
    Fang, Dexing
    Heimberger, Amy B.
    CANCERS, 2021, 13 (03) : 1 - 25
  • [23] Targeting JAK-STAT Signaling for Cancer Therapy
    Hedvat, Michael
    Huszar, Dennis
    Zinda, Michael
    Yu, Hua
    Jove, Richard
    JOURNAL OF IMMUNOTHERAPY, 2009, 32 (09) : 1004 - 1004
  • [24] Targeting the JAK/STAT Signaling Pathway for Breast Cancer
    Shao, Fei
    Pang, Xiaonan
    Baeg, Gyeong Hun
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (25) : 5137 - 5151
  • [25] The evolving role of JAK inhibitors in the treatment of inflammatory bowel disease
    Gupta, Nancy
    Papasotiriou, Sam
    Hanauer, Stephen
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (09) : 1075 - 1089
  • [26] Protective and anti-inflammatory role of REG1A in inflammatory bowel disease induced by JAK/STAT3 signaling axis
    Mao, Hongli
    Jia, Jinlin
    Sheng, Jinxiu
    Zhang, Shanfeng
    Huang, Kaida
    Li, Hongle
    He, Fucheng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 92
  • [27] Signaling pathways associated with bone loss in inflammatory bowel disease
    Palatianou, Maria E.
    Karamanolis, George
    Tsentidis, Charalambos
    Gourgiotis, Dimitrios
    Papaconstantinou, Ioannis
    Vezakis, Antonios
    Tzouvala, Maria
    ANNALS OF GASTROENTEROLOGY, 2023, 36 (02): : 132 - 140
  • [28] The involvement of JAK/STAT signaling pathway in the treatment of Parkinson's disease
    Lashgari, Naser-Aldin
    Roudsari, Nazanin Momeni
    Momtaz, Saeideh
    Sathyapalan, Thozhukat
    Abdolghaffari, Amir Hossein
    Sahebkar, Amirhossein
    JOURNAL OF NEUROIMMUNOLOGY, 2021, 361
  • [29] JAK inhibition in inflammatory bowel disease
    Olivera, Pablo
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (07) : 693 - 703
  • [30] Berberine as a natural modulator of inflammatory signaling pathways in the immune system: Focus on NF-κB, JAK/STAT, and MAPK signaling pathways
    Haftcheshmeh, Saeed Mohammadian
    Abedi, Maliheh
    Mashayekhi, Kazem
    Mousavi, Mohammad Javad
    Navashenaq, Jamshid Gholizadeh
    Mohammadi, Asadollah
    Momtazi-Borojeni, Amir Abbas
    PHYTOTHERAPY RESEARCH, 2022, 36 (03) : 1216 - 1230